PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

NCT07210320 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Food Allergy
Anaphylaxis
Food Hypersensitivity
Food Allergy Peanut

Interventions

DRUG: Epinephrine Auto-Injector 0.3 mg/0.3 mL
DRUG: Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle
DRUG: IN-001 9.06 mg Sublingual Spray
DRUG: IN-001 13.59 mg Sublingual Spray

Sponsor

Insignis Therapeutics, Inc.

Collaborators

[object Object]